2025-09-05 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
146,666 |
108,691 |
-25.89 |
2025-09-05 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
93,603 |
80,926 |
-13.54 |
2025-09-05 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
173,290 |
146,666 |
-15.36 |
2025-09-05 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
108,691 |
93,603 |
-13.88 |
2025-09-05 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
|
173,290 |
|
2025-09-05 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
1,236 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
0 |
15,426 |
|
2025-09-05 |
13F-HR |
ABCM
/ Abcam
|
Abn Amro Investment Solutions
|
|
952,460 |
|
2025-09-05 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
|
1,236 |
|
2025-09-05 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
14,586 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
ABCM
/ Abcam
|
Abn Amro Investment Solutions
|
269,884 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
1,395 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
942,741 |
35,550 |
-96.23 |
2025-09-05 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
928,735 |
942,741 |
1.51 |
2025-09-05 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
|
0 |
|
2025-09-05 |
13F-HR |
ABCM
/ Abcam
|
Abn Amro Investment Solutions
|
870,645 |
269,884 |
-69.00 |
2025-09-05 |
13F-HR |
PCVX
/ Vaxcyte
|
Abn Amro Investment Solutions
|
|
5,836 |
|
2025-09-05 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
929,358 |
930,927 |
0.17 |
2025-09-05 |
13F-HR |
ABCM
/ Abcam
|
Abn Amro Investment Solutions
|
952,460 |
870,645 |
-8.59 |
2025-09-05 |
SCHEDULE 13D/A |
VALN
/ Valneva SE - Depositary Receipt ()
|
Bpifrance Participations SA
|
14,113,834 |
21,810,176 |
54.53 |
2025-09-05 |
13F-HR |
PCVX
/ Vaxcyte
|
Abn Amro Investment Solutions
|
5,836 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
|
929,358 |
|
2025-09-05 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
930,927 |
928,735 |
-0.24 |
2025-09-05 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
|
1,395 |
|
2025-09-05 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
15,426 |
14,586 |
-5.45 |
2025-09-04 |
13F-HR/A |
AIMI
/ AIM ImmunoTech
|
Advisor Group Holdings, Inc.
|
1,001 |
0 |
-100.00 |
2025-09-04 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
2,118 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
CLLS
/ Cellectis S.A. - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
0 |
100 |
|
2025-09-04 |
13F-HR/A |
ARGX
/ argenx SE - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
2,066 |
1,948 |
-5.71 |
2025-09-04 |
13F-HR/A |
HUMA
/ Humacyte
|
Advisor Group Holdings, Inc.
|
95,000 |
93,240 |
-1.85 |
2025-09-04 |
13F-HR/A |
PASG
/ Passage Bio
|
Advisor Group Holdings, Inc.
|
|
2,000 |
|
2025-09-04 |
13F-HR/A |
CRBU
/ Caribou Biosciences
|
Advisor Group Holdings, Inc.
|
6,999 |
8,834 |
26.22 |
2025-09-04 |
13F-HR/A |
VALN
/ Valneva SE - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
1,300 |
1,855 |
42.69 |
2025-09-04 |
13F-HR/A |
PLX
/ Protalix BioTherapeutics
|
Advisor Group Holdings, Inc.
|
400 |
700 |
75.00 |
2025-09-04 |
13F-HR/A |
ARMP
/ Armata Pharmaceuticals
|
Advisor Group Holdings, Inc.
|
357 |
457 |
28.01 |
2025-09-04 |
13F-HR/A |
GILD
/ Gilead Sciences
|
Advisor Group Holdings, Inc.
|
196,949 |
204,115 |
3.64 |
2025-09-04 |
13F-HR/A |
TTNP
/ Titan Pharmaceuticals
|
Advisor Group Holdings, Inc.
|
15 |
10 |
-33.33 |
2025-09-04 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
35,550 |
35,248 |
-0.85 |
2025-09-04 |
13F-HR/A |
SABS
/ SAB Biotherapeutics
|
Advisor Group Holdings, Inc.
|
4,947 |
4,937 |
-0.20 |
2025-09-04 |
13F-HR/A |
ITOS
/ iTeos Therapeutics
|
Advisor Group Holdings, Inc.
|
40 |
56 |
40.00 |
2025-09-04 |
13F-HR/A |
BCAB
/ BioAtla
|
Advisor Group Holdings, Inc.
|
0 |
500 |
|
2025-09-04 |
13F-HR/A |
ELEV
/ Elevation Oncology
|
Advisor Group Holdings, Inc.
|
2,000 |
2,000 |
0.00 |
2025-09-04 |
13F-HR/A |
AIM
/ AIM ImmunoTech
|
Advisor Group Holdings, Inc.
|
|
10 |
|
2025-09-04 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
34,674 |
35,064 |
1.12 |
2025-09-04 |
13F-HR/A |
CGEM
/ Cullinan Therapeutics
|
Advisor Group Holdings, Inc.
|
0 |
2,115 |
|
2025-09-04 |
13F-HR/A |
VCEL
/ Vericel
|
Advisor Group Holdings, Inc.
|
2,584 |
2,937 |
13.66 |
2025-09-04 |
13F-HR/A |
NBIX
/ Neurocrine Biosciences
|
Advisor Group Holdings, Inc.
|
4,291 |
5,031 |
17.25 |
2025-09-04 |
13F-HR/A |
OCGN
/ Ocugen
|
Advisor Group Holdings, Inc.
|
55,231 |
5,575 |
-89.91 |
2025-09-04 |
13F-HR/A |
HALO
/ Halozyme Therapeutics
|
Advisor Group Holdings, Inc.
|
29,538 |
53,448 |
80.95 |
2025-09-04 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
0 |
4,295 |
|
2025-09-04 |
13F-HR/A |
IMTX
/ Immatics N.V.
|
Advisor Group Holdings, Inc.
|
0 |
337 |
|
2025-09-04 |
13F-HR/A |
REPL
/ Replimune Group
|
Advisor Group Holdings, Inc.
|
100 |
26,106 |
26,006.00 |
2025-09-04 |
13F-HR/A |
ALLO
/ Allogene Therapeutics
|
Advisor Group Holdings, Inc.
|
33,000 |
40,466 |
22.62 |
2025-09-04 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
0 |
2,118 |
|
2025-09-04 |
13F-HR/A |
MRNA
/ Moderna
|
Advisor Group Holdings, Inc.
|
43,644 |
46,709 |
7.02 |
2025-09-04 |
13F-HR/A |
PLUR
/ Pluri
|
Advisor Group Holdings, Inc.
|
51 |
50 |
-1.96 |
2025-09-04 |
13F-HR/A |
AGEN
/ Agenus
|
Advisor Group Holdings, Inc.
|
38,740 |
33,740 |
-12.91 |
2025-09-04 |
13F-HR/A |
CVM
/ CEL-SCI
|
Advisor Group Holdings, Inc.
|
289,093 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
LXEO
/ Lexeo Therapeutics
|
Advisor Group Holdings, Inc.
|
|
105 |
|
2025-09-04 |
13F-HR/A |
SCLX
/ Scilex Holding
|
Advisor Group Holdings, Inc.
|
|
232 |
|
2025-09-04 |
13F-HR/A |
KYTX
/ Kyverna Therapeutics
|
Advisor Group Holdings, Inc.
|
5,000 |
2,500 |
-50.00 |
2025-09-04 |
13F-HR/A |
TSHA
/ Taysha Gene Therapies
|
Advisor Group Holdings, Inc.
|
134 |
134 |
0.00 |
2025-09-04 |
13F-HR/A |
BNTX
/ BioNTech SE - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
1,531 |
1,949 |
27.30 |
2025-09-04 |
13F-HR/A |
TCRX
/ TScan Therapeutics
|
Advisor Group Holdings, Inc.
|
14,734 |
12,245 |
-16.89 |
2025-09-04 |
13F-HR/A |
ACLX
/ Arcellx
|
Advisor Group Holdings, Inc.
|
26 |
84 |
223.08 |
2025-09-04 |
13F-HR/A |
KYMR
/ Kymera Therapeutics
|
Advisor Group Holdings, Inc.
|
6 |
1,089 |
18,050.00 |
2025-09-04 |
13F-HR/A |
ADVM
/ Adverum Biotechnologies
|
Advisor Group Holdings, Inc.
|
145 |
1,689 |
1,064.83 |
2025-09-04 |
13F-HR/A |
SCLX
/ Scilex Holding
|
Advisor Group Holdings, Inc.
|
1,821 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
IPSC
/ Century Therapeutics
|
Advisor Group Holdings, Inc.
|
360 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
INKT
/ MiNK Therapeutics
|
Advisor Group Holdings, Inc.
|
238 |
120 |
-49.58 |
2025-09-04 |
13F-HR/A |
AUTL
/ Autolus Therapeutics plc - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
21,724 |
19,574 |
-9.90 |
2025-09-04 |
13F-HR/A |
ATHA
/ Athira Pharma
|
Advisor Group Holdings, Inc.
|
27,500 |
60,100 |
118.55 |
2025-09-04 |
13F-HR/A |
INBX
/ Inhibrx Biosciences
|
Advisor Group Holdings, Inc.
|
0 |
84 |
|
2025-09-04 |
13F-HR/A |
CVM
/ CEL-SCI
|
Advisor Group Holdings, Inc.
|
|
15,530 |
|
2025-09-04 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
4,295 |
3,693 |
-14.02 |
2025-09-04 |
13F-HR/A |
BDTX
/ Black Diamond Therapeutics
|
Advisor Group Holdings, Inc.
|
284 |
284 |
0.00 |
2025-09-04 |
13F-HR/A |
AVXL
/ Anavex Life Sciences
|
Advisor Group Holdings, Inc.
|
41,868 |
37,513 |
-10.40 |
2025-09-04 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
3,693 |
5,467 |
48.04 |
2025-09-04 |
13F-HR/A |
MGTX
/ MeiraGTx Holdings
|
Advisor Group Holdings, Inc.
|
100 |
250 |
150.00 |
2025-09-04 |
13F-HR/A |
PCVX
/ Vaxcyte
|
Advisor Group Holdings, Inc.
|
1,831 |
3,859 |
110.76 |
2025-09-04 |
13F-HR |
GILD
/ Gilead Sciences
|
SevenBridge Financial Group, LLC
|
8,696 |
8,486 |
-2.41 |
2025-09-04 |
13F-HR/A |
CELZ
/ Creative Medical Technology Holdings
|
Advisor Group Holdings, Inc.
|
1,261 |
1,130 |
-10.39 |
2025-09-04 |
13F-HR/A |
STRO
/ Sutro Biopharma
|
Advisor Group Holdings, Inc.
|
23,003 |
21,149 |
-8.06 |
2025-09-04 |
13F-HR/A |
BIIB
/ Biogen
|
Advisor Group Holdings, Inc.
|
7,794 |
8,735 |
12.07 |
2025-09-04 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
35,248 |
34,674 |
-1.63 |
2025-09-04 |
13F-HR/A |
FENC
/ Fennec Pharmaceuticals
|
Advisor Group Holdings, Inc.
|
338 |
94 |
-72.19 |
2025-09-04 |
13F-HR/A |
TWST
/ Twist Bioscience
|
Advisor Group Holdings, Inc.
|
5,360 |
7,054 |
31.60 |
2025-09-04 |
13F-HR/A |
FATE
/ Fate Therapeutics
|
Advisor Group Holdings, Inc.
|
2,205 |
3,385 |
53.51 |
2025-09-04 |
13F-HR/A |
ATRA
/ Atara Biotherapeutics
|
Advisor Group Holdings, Inc.
|
10 |
10 |
0.00 |
2025-09-04 |
13F-HR/A |
BCRX
/ BioCryst Pharmaceuticals
|
Advisor Group Holdings, Inc.
|
44,145 |
48,611 |
10.12 |
2025-09-04 |
13F-HR/A |
BCLI
/ Brainstorm Cell Therapeutics
|
Advisor Group Holdings, Inc.
|
1,719 |
1,785 |
3.84 |
2025-09-04 |
13F-HR/A |
VYGR
/ Voyager Therapeutics
|
Advisor Group Holdings, Inc.
|
4,206 |
4,133 |
-1.74 |
2025-09-04 |
13F-HR/A |
RGEN
/ Repligen
|
Advisor Group Holdings, Inc.
|
1,093 |
959 |
-12.26 |
2025-09-04 |
13F-HR/A |
VIVS
/ VivoSim Labs
|
Advisor Group Holdings, Inc.
|
133 |
117 |
-12.03 |
2025-09-04 |
13F-HR/A |
TRML
/ Tourmaline Bio
|
Advisor Group Holdings, Inc.
|
250 |
251 |
0.40 |
2025-09-04 |
13F-HR/A |
GLUE
/ Monte Rosa Therapeutics
|
Advisor Group Holdings, Inc.
|
1,158 |
2,284 |
97.24 |
2025-09-04 |
13F-HR/A |
EXEL
/ Exelixis
|
Advisor Group Holdings, Inc.
|
27,109 |
68,276 |
151.86 |
2025-09-04 |
13F-HR/A |
IBRX
/ ImmunityBio
|
Advisor Group Holdings, Inc.
|
152,525 |
201,759 |
32.28 |
2025-09-04 |
13F-HR/A |
SANA
/ Sana Biotechnology
|
Advisor Group Holdings, Inc.
|
4,065 |
3,247 |
-20.12 |
2025-09-04 |
13F-HR/A |
KRYS
/ Krystal Biotech
|
Advisor Group Holdings, Inc.
|
278 |
393 |
41.37 |
2025-09-04 |
13F-HR/A |
RGNX
/ REGENXBIO
|
Advisor Group Holdings, Inc.
|
275 |
492 |
78.91 |
2025-09-04 |
13F-HR/A |
SWTX
/ SpringWorks Therapeutics
|
Advisor Group Holdings, Inc.
|
261 |
2,266 |
768.20 |
2025-09-04 |
13F-HR/A |
IMCR
/ Immunocore Holdings plc - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
1,448 |
3,148 |
117.40 |
2025-09-04 |
13F-HR/A |
LCTX
/ Lineage Cell Therapeutics
|
Advisor Group Holdings, Inc.
|
97,252 |
81,477 |
-16.22 |
2025-09-04 |
13F-HR/A |
CRDF
/ Cardiff Oncology
|
Advisor Group Holdings, Inc.
|
2,000 |
2,012 |
0.60 |
2025-09-04 |
13F-HR/A |
QNCX
/ Quince Therapeutics
|
Advisor Group Holdings, Inc.
|
277 |
277 |
0.00 |
2025-09-04 |
13F-HR/A |
AMGN
/ Amgen
|
Advisor Group Holdings, Inc.
|
1 |
1 |
0.00 |
2025-09-04 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
80,926 |
69,758 |
-13.80 |
2025-09-04 |
13F-HR/A |
VIR
/ Vir Biotechnology
|
Advisor Group Holdings, Inc.
|
3,882 |
5,509 |
41.91 |
2025-09-04 |
13F-HR/A |
CRSP
/ CRISPR Therapeutics
|
Advisor Group Holdings, Inc.
|
4 |
3 |
-25.00 |
2025-09-04 |
13F-HR/A |
KOD
/ Kodiak Sciences
|
Advisor Group Holdings, Inc.
|
10,185 |
9,490 |
-6.82 |
2025-09-04 |
13F-HR/A |
BEAM
/ Beam Therapeutics
|
Advisor Group Holdings, Inc.
|
6,056 |
6,580 |
8.65 |
2025-09-04 |
13F-HR/A |
CGEN
/ Compugen
|
Advisor Group Holdings, Inc.
|
9,840 |
43,885 |
345.99 |
2025-09-04 |
13F-HR/A |
AURA
/ Aura Biosciences
|
Advisor Group Holdings, Inc.
|
0 |
263 |
|
2025-09-04 |
13F-HR/A |
DTIL
/ Precision BioSciences
|
Advisor Group Holdings, Inc.
|
0 |
75 |
|
2025-09-04 |
13F-HR/A |
SRRK
/ Scholar Rock Holding
|
Advisor Group Holdings, Inc.
|
1,781 |
1,922 |
7.92 |
2025-09-04 |
13F-HR/A |
JSPR
/ Jasper Therapeutics
|
Advisor Group Holdings, Inc.
|
837 |
837 |
0.00 |
2025-09-04 |
13F-HR/A |
ABOS
/ Acumen Pharmaceuticals
|
Advisor Group Holdings, Inc.
|
5,000 |
7,251 |
45.02 |
2025-09-04 |
13F-HR/A |
SNTI
/ Senti Biosciences
|
Advisor Group Holdings, Inc.
|
6,400 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
GNFT
/ Genfit S.A. - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
0 |
225 |
|
2025-09-04 |
13F-HR/A |
CCCC
/ C4 Therapeutics
|
Advisor Group Holdings, Inc.
|
0 |
1,500 |
|
2025-09-04 |
13F-HR/A |
RVMDW
/ Revolution Medicines, Inc. - Equity Warrant
|
Advisor Group Holdings, Inc.
|
64 |
64 |
0.00 |
2025-09-04 |
13F-HR/A |
VXRT
/ Vaxart
|
Advisor Group Holdings, Inc.
|
15,435 |
15,435 |
0.00 |
2025-09-04 |
13F-HR |
ADAP
/ Adaptimmune Therapeutics plc - Depositary Receipt ()
|
V. M. Manning & Co., Inc.
|
|
22,200 |
|
2025-09-04 |
13F-HR/A |
CRIS
/ Curis
|
Advisor Group Holdings, Inc.
|
1,510 |
1,510 |
0.00 |
2025-09-04 |
13F-HR/A |
PMCB
/ PharmaCyte Biotech
|
Advisor Group Holdings, Inc.
|
10 |
305 |
2,950.00 |
2025-09-04 |
13F-HR/A |
SGMO
/ Sangamo Therapeutics
|
Advisor Group Holdings, Inc.
|
3,960 |
7,130 |
80.05 |
2025-09-04 |
13F-HR/A |
CRGX
/ CARGO Therapeutics
|
Advisor Group Holdings, Inc.
|
0 |
53 |
|
2025-09-04 |
13F-HR/A |
CADL
/ Candel Therapeutics
|
Advisor Group Holdings, Inc.
|
13,805 |
11,875 |
-13.98 |
2025-09-04 |
13F-HR/A |
ADAP
/ Adaptimmune Therapeutics plc - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
65,058 |
90,058 |
38.43 |
2025-09-04 |
13F-HR/A |
VIGL
/ Vigil Neuroscience
|
Advisor Group Holdings, Inc.
|
501 |
565 |
12.77 |
2025-09-04 |
13F-HR/A |
RLAY
/ Relay Therapeutics
|
Advisor Group Holdings, Inc.
|
1,801 |
1,913 |
6.22 |
2025-09-04 |
13F-HR/A |
ADMA
/ ADMA Biologics
|
Advisor Group Holdings, Inc.
|
67,747 |
66,172 |
-2.32 |
2025-09-04 |
13F-HR/A |
ADPT
/ Adaptive Biotechnologies
|
Advisor Group Holdings, Inc.
|
69,914 |
95,493 |
36.59 |
2025-09-04 |
13F-HR |
IBRX
/ ImmunityBio
|
ZynergyRetirementPlanningLLC
|
1,950 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
RVMD
/ Revolution Medicines
|
Advisor Group Holdings, Inc.
|
2,460 |
3,487 |
41.75 |
2025-09-04 |
13F-HR/A |
DBVT
/ DBV Technologies S.A. - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
11 |
11 |
0.00 |
2025-09-04 |
13F-HR/A |
QGEN
/ Qiagen N.V.
|
Advisor Group Holdings, Inc.
|
1,924 |
3,875 |
101.40 |
2025-09-04 |
13F-HR |
AMGN
/ Amgen
|
Reynders McVeigh Capital Management, LLC
|
9,394 |
9,049 |
-3.67 |
2025-09-04 |
13F-HR |
RGEN
/ Repligen
|
Abn Amro Investment Solutions
|
|
|
|
2025-09-04 |
13F-HR/A |
TECH
/ Bio-Techne
|
Advisor Group Holdings, Inc.
|
21,295 |
15,564 |
-26.91 |
2025-09-04 |
13F-HR/A |
OTLK
/ Outlook Therapeutics
|
Advisor Group Holdings, Inc.
|
0 |
3,340 |
|
2025-09-04 |
13F-HR/A |
NVAX
/ Novavax
|
Advisor Group Holdings, Inc.
|
52,175 |
48,970 |
-6.14 |
2025-09-04 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
69,758 |
60,828 |
-12.80 |
2025-09-04 |
13F-HR |
AMGN
/ Amgen
|
SevenBridge Financial Group, LLC
|
13,453 |
11,148 |
-17.13 |
2025-09-04 |
13F-HR/A |
AMGN
/ Amgen
|
Advisor Group Holdings, Inc.
|
159,318 |
163,516 |
2.63 |
2025-09-04 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
60,828 |
65,852 |
8.26 |
2025-09-04 |
13F-HR/A |
BLUE
/ bluebird bio
|
Advisor Group Holdings, Inc.
|
5,476 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
MESO
/ Mesoblast Limited - Depositary Receipt ()
|
Advisor Group Holdings, Inc.
|
859 |
857 |
-0.23 |
2025-09-04 |
13F-HR/A |
CRSP
/ CRISPR Therapeutics
|
Advisor Group Holdings, Inc.
|
43,663 |
52,035 |
19.17 |
2025-09-04 |
13F-HR/A |
CGTX
/ Cognition Therapeutics
|
Advisor Group Holdings, Inc.
|
7,200 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
RXRX
/ Recursion Pharmaceuticals
|
Advisor Group Holdings, Inc.
|
262,708 |
248,597 |
-5.37 |
2025-09-04 |
13F-HR/A |
FDMT
/ 4D Molecular Therapeutics
|
Advisor Group Holdings, Inc.
|
5 |
10 |
100.00 |
2025-09-04 |
13F-HR/A |
ALEC
/ Alector
|
Advisor Group Holdings, Inc.
|
840 |
1,120 |
33.33 |
2025-09-04 |
13F-HR/A |
INMB
/ INmune Bio
|
Advisor Group Holdings, Inc.
|
13,925 |
12,510 |
-10.16 |
2025-09-04 |
13F-HR/A |
SLDB
/ Solid Biosciences
|
Advisor Group Holdings, Inc.
|
30 |
30 |
0.00 |
2025-09-04 |
13F-HR/A |
CHRS
/ Coherus Oncology
|
Advisor Group Holdings, Inc.
|
2,618 |
983 |
-62.45 |
2025-09-04 |
13F-HR/A |
IMVT
/ Immunovant
|
Advisor Group Holdings, Inc.
|
2,916 |
2,709 |
-7.10 |
2025-09-04 |
13F-HR/A |
ALGS
/ Aligos Therapeutics
|
Advisor Group Holdings, Inc.
|
220 |
220 |
0.00 |
2025-09-04 |
13F-HR/A |
TARS
/ Tarsus Pharmaceuticals
|
Advisor Group Holdings, Inc.
|
316 |
2,778 |
779.11 |
2025-09-04 |
13F-HR/A |
EVAX
/ Evaxion A
|
Advisor Group Holdings, Inc.
|
25 |
25 |
0.00 |
2025-09-04 |
13F-HR/A |
IVVD
/ Invivyd
|
Advisor Group Holdings, Inc.
|
17 |
17 |
0.00 |
2025-09-04 |
13F-HR |
AMGN
/ Amgen
|
ZynergyRetirementPlanningLLC
|
40 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
TARA
/ Protara Therapeutics
|
Advisor Group Holdings, Inc.
|
100 |
100 |
0.00 |
2025-09-04 |
13F-HR |
CRSP
/ CRISPR Therapeutics
|
Reynders McVeigh Capital Management, LLC
|
101,773 |
111,431 |
9.49 |
2025-09-04 |
13F-HR/A |
TNYA
/ Tenaya Therapeutics
|
Advisor Group Holdings, Inc.
|
34,664 |
34,000 |
-1.92 |
2025-09-04 |
13F-HR/A |
CGON
/ CG Oncology
|
Advisor Group Holdings, Inc.
|
0 |
331 |
|
2025-09-04 |
13F-HR/A |
APGE
/ Apogee Therapeutics
|
Advisor Group Holdings, Inc.
|
2 |
248 |
12,300.00 |
2025-09-04 |
13F-HR/A |
EDIT
/ Editas Medicine
|
Advisor Group Holdings, Inc.
|
12,927 |
15,597 |
20.65 |
2025-09-04 |
13F-HR/A |
CSBR
/ Champions Oncology
|
Advisor Group Holdings, Inc.
|
100 |
0 |
-100.00 |
2025-09-04 |
13F-HR/A |
DNLI
/ Denali Therapeutics
|
Advisor Group Holdings, Inc.
|
1,048 |
1,595 |
52.19 |
2025-09-04 |
13F-HR/A |
IOVA
/ Iovance Biotherapeutics
|
Advisor Group Holdings, Inc.
|
42,979 |
88,856 |
106.74 |
2025-09-04 |
13F-HR/A |
BCDA
/ BioCardia
|
Advisor Group Holdings, Inc.
|
62 |
62 |
0.00 |
2025-09-03 |
NPORT-P |
IMCR
/ Immunocore Holdings plc - Depositary Receipt ()
|
MMNIX - Miller Investment Trust - Miller Market Neutral Income Fund Class I
|
-5,200 |
-7,200 |
38.46 |
2025-09-03 |
13F-HR |
EXEL
/ Exelixis
|
American Trust
|
|
4,870 |
|
2025-09-03 |
NPORT-P |
RGEN
/ Repligen
|
MMNIX - Miller Investment Trust - Miller Market Neutral Income Fund Class I
|
-2,900 |
-2,400 |
-17.24 |
2025-09-03 |
13F-HR |
GILD
/ Gilead Sciences
|
Q3 Asset Management
|
31,125 |
0 |
-100.00 |
2025-09-03 |
SCHEDULE 13D/A |
ITOS
/ iTeos Therapeutics
|
Tang Capital Management Llc
|
3,826,692 |
10,000 |
-99.74 |
2025-09-03 |
NPORT-P |
HALO
/ Halozyme Therapeutics
|
MMNIX - Miller Investment Trust - Miller Market Neutral Income Fund Class I
|
-16,400 |
-15,000 |
-8.54 |
2025-09-02 |
13F-HR/A |
BIIB
/ Biogen
|
Harwood Advisory Group, LLC
|
16 |
16 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR/A |
GILD
/ Gilead Sciences
|
Aegon Asset Management Uk Plc
|
1,241,553 |
1,145,892 |
-7.70 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
0 |
-100.00 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
|
3,000 |
|
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR/A |
GILD
/ Gilead Sciences
|
FSC Wealth Advisors, LLC
|
144 |
0 |
-100.00 |
2025-09-02 |
13F-HR/A |
GILD
/ Gilead Sciences
|
Harwood Advisory Group, LLC
|
209 |
210 |
0.48 |
2025-09-02 |
13F-HR |
AVXL
/ Anavex Life Sciences
|
Pvg Asset Management Corp
|
82,608 |
111,445 |
34.91 |
2025-09-02 |
13F-HR |
BCAB
/ BioAtla
|
Pvg Asset Management Corp
|
65,000 |
65,000 |
0.00 |
2025-09-02 |
13F-HR/A |
TWST
/ Twist Bioscience
|
Aegon Asset Management Uk Plc
|
|
328,551 |
|
2025-09-02 |
13F-HR/A |
ABCM
/ Abcam
|
Aegon Asset Management Uk Plc
|
1,086,052 |
485,685 |
-55.28 |
2025-09-02 |
13F-HR |
GILD
/ Gilead Sciences
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
3,000 |
3,000 |
0.00 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
1,500 |
4,000 |
166.67 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
1,500 |
1,500 |
0.00 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
1,500 |
1,500 |
0.00 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
4,000 |
4,500 |
12.50 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
|
4,000 |
|
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
4,500 |
1,500 |
-66.67 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
4,500 |
4,500 |
0.00 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
4,000 |
4,000 |
0.00 |
2025-09-02 |
13F-HR |
RGNX
/ REGENXBIO
|
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
|
4,500 |
4,500 |
0.00 |